Our senior management team works tirelessly to create an environment where excellent research thrives. They lead our administration and corporate services, facilities, IT and research services teams and provide our researchers with the specialized support that enables innovative research.
Senior Executive Director, Research
Dr. Quynh Doan
Executive Coordinator: Erika Kosuge, 604-875-2404
Associate Director, Foundational Science
Dr. Angela Devlin
604-875-2000 ext 5378
Associate Director, Research Community
Dr. Jill Zwicker
(604) 875-2345 ext. 5948
Executive Director, Research Administration and Operations
Vicki Chiu
604-875-2488
Executive Coordinator: Erika Kosuge, 604-875-2404
Clinical Research Operations
Jennifer Claydon, Director
604-875-2448
Research Communications
Jonathan Ho, Manager
604-219-4685
Research Ethics Board
Jennie Prasad, Director
604-875-2441
Administrative Coordinator: Talysa Dhahan, 604-875-3013
Research Facilities
Todd Jacques, Director
604-875-2409
Administrative Assistant: Tracy Aomoto, 604-875-2000 ext. 2435
Research Finance
Kelly Chan, Senior Manager
604-875-2000 ext. 6771
Research Informatics
Dr. Tibor van Rooij, Director
250-686-2934
Research IT
Robert Chrisp, Manager
604-875-2000 ext. 4958
Administrative Coordinator: Twinky Ip, 604-875-2000 ext. 5433
Research & Technology Development Office
Dr. Dawn McArthur, Director
604-875-3105
Research Services
Isabelle Linden, Director
604-875-2000 ext. 2108
We need you today for a better tomorrow. Our kids are counting on it.
A pan-Canadian team has developed a new way to quickly find personalized treatments for young cancer patients, by growing their tumours in chicken eggs and analyzing their proteins.
The team, led by researchers from BC Children’s Hospital Research Institute and the University of British Columbia, is the first in Canada to combine these two techniques to identify and test a drug for a young patient's tumour in time for their treatment.
We believe there’s nothing we can’t do with your support. It can take years to turn scientific breakthrough into new interventions and treatments. Funding helps speed the pace of change. When given the resources, we can bring transformative therapies – and hope – out of the laboratory and into the clinic to save and improve children’s lives.